# Moderna, Inc. (MRNA) FY2024 Q3 P&L / Income Statement - Company: Moderna, Inc. (MRNA) - Period: 2024-07-01 to 2024-09-30 - Filing: Q3 FY2024 10-Q, filed 2024-11-07, accession number 0001682852-24-000060 - Page: https://plicit.ai/financials/mrna/fy2024-q3-income-statement - Chart image: https://plicit.ai/charts/mrna-fy2024-q3-income-statement-sankey.png ## Chart details: Revenue by Product and Service by Geography Income statement for 2024-07-01 through 2024-09-30. View: Product and Service by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total revenue**: 1,862,000,000 US dollars - **Cost of sales**: 514,000,000 US dollars - **Gross profit (calculated)**: 1,348,000,000 US dollars - **Operating expenses (calculated)**: 1,418,000,000 US dollars - **Loss from operations**: negative 70,000,000 US dollars - **Other income (expense), net (calculated)**: 91,000,000 US dollars - **Income (loss) before income taxes**: 21,000,000 US dollars - **Provision for income taxes**: 8,000,000 US dollars - **Net income (loss)**: 13,000,000 US dollars - **Licensing and royalty revenue**: 7,000,000 US dollars - **Grant revenue**: 7,000,000 US dollars - **Collaboration revenue**: 28,000,000 US dollars - **Net product sales - UNITED STATES**: 1,215,000,000 US dollars - **Net product sales - Rest of world**: 324,000,000 US dollars - **Net product sales - Europe**: 281,000,000 US dollars - **Research and development**: 1,137,000,000 US dollars - **Selling, general and administrative**: 281,000,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Product and Service (4) - Page: https://plicit.ai/financials/mrna/fy2024-q3-income-statement/revenue-by-product-and-service-4 - Chart image: https://plicit.ai/charts/mrna-fy2024-q3-revenue-by-product-and-service-4-sankey.png Income statement for 2024-07-01 through 2024-09-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total revenue**: 1,862,000,000 US dollars - **Cost of sales**: 514,000,000 US dollars - **Gross profit (calculated)**: 1,348,000,000 US dollars - **Operating expenses (calculated)**: 1,418,000,000 US dollars - **Loss from operations**: negative 70,000,000 US dollars - **Other income (expense), net (calculated)**: 91,000,000 US dollars - **Income (loss) before income taxes**: 21,000,000 US dollars - **Provision for income taxes**: 8,000,000 US dollars - **Net income (loss)**: 13,000,000 US dollars - **Net product sales**: 1,820,000,000 US dollars - **Other revenue**: 42,000,000 US dollars - **Research and development**: 1,137,000,000 US dollars - **Selling, general and administrative**: 281,000,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Product and Service - Page: https://plicit.ai/financials/mrna/fy2024-q3-income-statement/revenue-by-product-and-service - Chart image: https://plicit.ai/charts/mrna-fy2024-q3-revenue-by-product-and-service-sankey.png Income statement for 2024-07-01 through 2024-09-30. View: Product and service (Schedule of Disaggregation of Revenue). Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total revenue**: 1,862,000,000 US dollars - **Cost of sales**: 514,000,000 US dollars - **Gross profit (calculated)**: 1,348,000,000 US dollars - **Operating expenses (calculated)**: 1,418,000,000 US dollars - **Loss from operations**: negative 70,000,000 US dollars - **Other income (expense), net (calculated)**: 91,000,000 US dollars - **Income (loss) before income taxes**: 21,000,000 US dollars - **Provision for income taxes**: 8,000,000 US dollars - **Net income (loss)**: 13,000,000 US dollars - **Grant revenue**: 7,000,000 US dollars - **Collaboration revenue**: 28,000,000 US dollars - **Licensing and royalty revenue**: 7,000,000 US dollars - **Total other revenue**: 42,000,000 US dollars - **Undisclosed (calculated)**: 1,778,000,000 US dollars - **Research and development**: 1,137,000,000 US dollars - **Selling, general and administrative**: 281,000,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Product and Service (2) - Page: https://plicit.ai/financials/mrna/fy2024-q3-income-statement/revenue-by-product-and-service-2 - Chart image: https://plicit.ai/charts/mrna-fy2024-q3-revenue-by-product-and-service-2-sankey.png Income statement for 2024-07-01 through 2024-09-30. View: Product and service (Schedule of Revenue from External Customers by Geographic Areas). Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total revenue**: 1,862,000,000 US dollars - **Cost of sales**: 514,000,000 US dollars - **Gross profit (calculated)**: 1,348,000,000 US dollars - **Operating expenses (calculated)**: 1,418,000,000 US dollars - **Loss from operations**: negative 70,000,000 US dollars - **Other income (expense), net (calculated)**: 91,000,000 US dollars - **Income (loss) before income taxes**: 21,000,000 US dollars - **Provision for income taxes**: 8,000,000 US dollars - **Net income (loss)**: 13,000,000 US dollars - **COVID-19**: 1,810,000,000 US dollars - **RSV**: 10,000,000 US dollars - **Other revenue**: 42,000,000 US dollars - **Research and development**: 1,137,000,000 US dollars - **Selling, general and administrative**: 281,000,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Product and Service (3) - Page: https://plicit.ai/financials/mrna/fy2024-q3-income-statement/revenue-by-product-and-service-3 - Chart image: https://plicit.ai/charts/mrna-fy2024-q3-revenue-by-product-and-service-3-sankey.png Income statement for 2024-07-01 through 2024-09-30. View: Product and service (Narrative). Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total revenue**: 1,862,000,000 US dollars - **Cost of sales**: 514,000,000 US dollars - **Gross profit (calculated)**: 1,348,000,000 US dollars - **Operating expenses (calculated)**: 1,418,000,000 US dollars - **Loss from operations**: negative 70,000,000 US dollars - **Other income (expense), net (calculated)**: 91,000,000 US dollars - **Income (loss) before income taxes**: 21,000,000 US dollars - **Provision for income taxes**: 8,000,000 US dollars - **Net income (loss)**: 13,000,000 US dollars - **Grant revenue**: 7,000,000 US dollars - **Licensing and royalty revenue**: 7,000,000 US dollars - **Other revenue**: 42,000,000 US dollars - **Undisclosed (calculated)**: 1,806,000,000 US dollars - **Research and development**: 1,137,000,000 US dollars - **Selling, general and administrative**: 281,000,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.